Profile: Kosan Biosciences Incorporated is a cancer therapeutics company focused on advancing two new classes of anticancer agents through clinical development such as heat shock protein 90 inhibitors and epothilones. Our Hsp90 inhibitors have a novel mechanism of action targeting multiple pathways involved in cancer cell growth and survival.
4 Products/Services (Click for related suppliers)
| |||||
• | Epothilones | • | Hsp90 Inhibitors | • | Motilides |
• | Nuclear Export Inhibitors |